Status:
UNKNOWN
Ultrasound Guided Port-A-Cath Isertion in Cancer Patients
Lead Sponsor:
Omar Mokhtar Hussein
Conditions:
Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
Port-A-Cath is a totally implanted central venous access system and one of the most frequently used systems for administration of chemotherapies in oncological patients . The currently used technique...
Eligibility Criteria
Inclusion
- cancer patients
- Indicated for receiving long term chemotherapy
- Accepted coagulation profile.
Exclusion
- Severe uncorrectable coagulopathy.
- Prior incidence of central vein thrombosis.
- Patients with active infection.
Key Trial Info
Start Date :
October 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04103021
Start Date
October 30 2019
End Date
October 30 2020
Last Update
September 25 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.